Tenet Healthcare CORP 8-K filings

Tenet Healthcare Corporation announced robust second quarter 2026 financial results, exceeding expectations and leading to an upward revision of its full-year 2026 financial guidance.

Tenet Healthcare Corporation shareholders re-elected all director nominees and approved executive compensation at the 2026 Annual Meeting.

Tenet Healthcare Corporation announced robust first quarter 2026 financial results, driven by strong performance in its Ambulatory and Hospital segments, with net income available to common shareholders reaching $702 million.

Tenet Healthcare announces a planned retirement transition for its Executive Vice President and Chief Information Officer, Paola Arbour, with a phased handover and continued part-time support.

Tenet Healthcare Corporation announced strong financial results for the fourth quarter and full year 2025, alongside a positive financial outlook for 2026.

Tenet Healthcare announced the completion of a strategic transaction with CommonSpirit Health for its Conifer Health Solutions subsidiary and expects 2025 Adjusted EBITDA at the upper end of its guidance.

Stephen H. Rusckowski has resigned from Tenet Healthcare Corporation's board of directors, leading to a reduction in the board's size from thirteen to twelve members.

Tenet Healthcare Corporation issued $2.25 billion in new senior notes to refinance existing debt, extending maturities and adjusting interest rates.

Tenet Healthcare Corporation has entered into a new $1.9 billion senior secured revolving credit facility and extended its existing $200 million letter of credit facility to November 2030.

Tenet Healthcare Corporation announced the pricing and upsizing of $2.25 billion in new senior notes to refinance existing debt, extending maturities and reducing interest rates.

Tenet Healthcare Corporation announced robust third-quarter 2025 financial results, including significant growth in Adjusted EBITDA and diluted earnings per share, leading to an increased full-year 2025 financial outlook.

Tenet Healthcare Corporation announced robust second quarter 2025 financial results, including significant growth in Adjusted EBITDA and diluted earnings per share, leading to an upward revision of its full-year 2025 financial guidance and a substantial increase in its share repurchase authorization.

Tenet Healthcare Corporation announced the promotion of Lisa Y. Foo to the newly created position of Chief Operating Officer, effective May 30, 2025.

Tenet Healthcare Corporation announced the results of its 2025 Annual Meeting of Shareholders, confirming the election of all director nominees, the advisory approval of executive compensation, and the ratification of Deloitte & Touche LLP as independent auditors.

Tenet Healthcare announced strong first quarter 2025 results, with net income available to common shareholders at $406 million and adjusted diluted earnings per share increasing by 35.4% to $4.36.

Tenet Healthcare announces robust Q4 and FY 2024 results driven by revenue growth and efficient operations, with a promising financial outlook for 2025.

Tenet Healthcare Corporation has entered into an amended employment agreement with CEO Saumya Sutaria, including an $18 million retention grant and extended term through 2028.

Tenet Healthcare announced strong third-quarter results, including a significant increase in net income and adjusted EBITDA, and raised its full-year 2024 financial outlook.

Tenet Healthcare has agreed to sell its 70% ownership in five Alabama hospitals to Orlando Health for approximately $910 million in cash, while also reaffirming its full-year 2024 Adjusted EBITDA outlook.

Tenet Healthcare reported strong second-quarter 2024 results, driven by volume and revenue growth, leading to an increased full-year financial outlook and a new $1.5 billion share repurchase program.

Tenet Healthcare Corporation held its 2024 Annual Meeting of Shareholders, electing directors, approving executive compensation on an advisory basis, and ratifying the selection of Deloitte & Touche LLP as its independent auditor.

Tenet Healthcare reported a strong first quarter in 2024, surpassing guidance with significant gains from hospital divestitures and improved operational performance, leading to an increased financial outlook for the year.

Tenet Healthcare Corporation has completed the sale of six hospitals in California to UCI Health and Adventist Health, respectively.

Tenet Healthcare has announced the sale of two hospitals in California for $550 million in cash and a new revenue cycle services partnership with Adventist Health.

Tenet Healthcare Corporation announced it will redeem all $2.1 billion of its 4.875% Senior Secured First Lien Notes due 2026 on March 5, 2024.

Tenet Healthcare Corporation announced robust financial results for the fourth quarter and full year 2023, alongside a positive financial outlook for 2024, driven by strong revenue growth and disciplined management.

Tenet Healthcare finalized the sale of three South Carolina hospitals and related assets to Novant Health for $2.4 billion, anticipating a $1.7 billion pretax gain.

Tenet Healthcare anticipates exceeding its Adjusted EBITDA guidance for 2023 and has agreed to sell four California hospitals for $975 million.